Title:
腎機能障害を有するファブリー患者の治療方法
Document Type and Number:
Japanese Patent JP6788725
Kind Code:
B2
Abstract:
Provided are methods for treatment of Fabry disease in patients having HEK assay amenable mutations in α-galactosidase A. Certain methods comprise administering migalastat or a salt thereof every other day, such as administering about 150 mg of migalastat hydrochloride every other day.
Inventors:
Castelli Jeff
Application Number:
JP2019229050A
Publication Date:
November 25, 2020
Filing Date:
December 19, 2019
Export Citation:
Assignee:
Amicus Therapeutics, Inc.
International Classes:
A61K31/445; A61P3/00; A61P9/00; A61P13/12; A61P43/00
Domestic Patent References:
| JP2010525084A |
Attorney, Agent or Firm:
Sonoda/Kobayashi Patent Business Corporation